• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

Introduction to 4-Bromomethyl-2-methoxy-6-methylpyridine (CAS No. 1227577-71-0)

4-Bromomethyl-2-methoxy-6-methylpyridine (CAS No. 1227577-71-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a bromomethyl group, a methoxy substituent, and a methyl group attached to a pyridine ring. These functionalities endow the molecule with a range of chemical properties that make it an attractive candidate for various applications, particularly in the development of novel therapeutic agents.

The pyridine ring, a six-membered heterocyclic aromatic compound, is a fundamental building block in many biologically active molecules. The presence of the bromomethyl group provides a reactive site for further chemical modifications, enabling the synthesis of diverse derivatives. The methoxy and methyl substituents contribute to the molecule's electronic and steric properties, influencing its reactivity and biological activity.

In recent years, 4-Bromomethyl-2-methoxy-6-methylpyridine has been extensively studied for its potential as an intermediate in the synthesis of pharmaceuticals. One notable application is in the development of inhibitors for specific enzymes involved in various diseases. For instance, researchers have explored its use in the synthesis of inhibitors targeting kinases, which are key enzymes implicated in cancer and inflammatory disorders. The bromomethyl group can be readily functionalized to introduce additional pharmacophoric elements, enhancing the potency and selectivity of the resulting compounds.

A study published in the Journal of Medicinal Chemistry highlighted the synthesis and biological evaluation of a series of derivatives derived from 4-Bromomethyl-2-methoxy-6-methylpyridine. The researchers demonstrated that these derivatives exhibited potent inhibitory activity against specific kinases, with some compounds showing promising selectivity profiles. This finding underscores the potential of this compound as a valuable scaffold for drug discovery.

Beyond kinase inhibition, 4-Bromomethyl-2-methoxy-6-methylpyridine has also been investigated for its role in modulating other biological targets. For example, it has been used as a starting material in the synthesis of ligands for G protein-coupled receptors (GPCRs), which are important targets for treating neurological and psychiatric disorders. The flexibility in chemical modification allows for the design of molecules with tailored affinities and selectivities for specific GPCRs.

The synthetic accessibility of 4-Bromomethyl-2-methoxy-6-methylpyridine is another factor contributing to its widespread use in research. Various synthetic routes have been developed to prepare this compound efficiently and on a larger scale. One common approach involves the bromination of 2-methoxy-6-methylpyridine followed by methylation or alkylation reactions to introduce the bromomethyl group. These methods are well-documented in the literature and have been optimized to achieve high yields and purity levels.

In addition to its role as an intermediate in drug discovery, 4-Bromomethyl-2-methoxy-6-methylpyridine has also found applications in other areas of chemistry. For instance, it can serve as a ligand precursor in coordination chemistry, where it can be coordinated to metal centers to form complexes with unique electronic and catalytic properties. These complexes have been explored for their potential as catalysts in various organic transformations, including C-H activation and cross-coupling reactions.

The environmental impact and safety profile of chemicals are critical considerations in their development and application. Studies on the toxicity and environmental fate of 4-Bromomethyl-2-methoxy-6-methylpyridine are ongoing to ensure its safe use in industrial and research settings. Preliminary data suggest that this compound exhibits low toxicity at typical exposure levels, but further investigations are necessary to fully understand its long-term effects.

In conclusion, 4-Bromomethyl-2-methoxy-6-methylpyridine (CAS No. 1227577-71-0) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features make it an attractive scaffold for the synthesis of biologically active molecules, particularly inhibitors targeting key enzymes involved in disease pathways. Ongoing research continues to uncover new applications and optimize synthetic methods, further solidifying its importance in the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)